This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc., headquartered in the United States, is a pioneering biopharmaceutical company dedicated to developing and commercialising innovative therapies for rare diseases. Founded in 2011, Leadiant has made significant strides in the industry, focusing on areas such as metabolic disorders and orphan diseases. The company’s core products, including its unique formulations and therapies, are designed to address unmet medical needs, setting them apart in a competitive market. With a commitment to patient-centric solutions, Leadiant has established a strong market position, recognised for its contributions to improving the quality of life for patients with rare conditions. Through its ongoing research and development efforts, Leadiant continues to advance the field of biosciences, making a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Leadiant Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Leadiant Biosciences, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Leadiant Biosciences, Inc.'s reported carbon emissions
Leadiant Biosciences, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Leadiant Biosciences, Inc. may inherit climate-related data and initiatives from its parent organisation; however, no specific details have been provided regarding such cascaded information. The company has not publicly committed to any Science-Based Targets Initiative (SBTi) or other industry-standard climate initiatives at this time. In the context of the biopharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. While Leadiant Biosciences, Inc. has yet to establish its own emissions data or reduction commitments, it is essential for organisations in this sector to align with global climate goals and demonstrate accountability in their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Leadiant Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
